Application of Nanotechnology in Cancer Diagnosis, Biomarker Discovery, and Drug Discovery

The intersection of cardiovascular, neurological, and oncological pathologies, termed cardio-brain oncology, represents a complex and emerging frontier in medical research. Central to this landscape are critical signaling pathways and genetic markers that drive tumor initiation, progression, and resistance within cardiovascular and neural tissues affected by metastatic cancers or primary tumors. Nanotechnology offers transformative potentials in this domain by enabling highly sensitive detection and targeted modulation of these molecular determinants. This chapter explores how nanomaterials and nanoscale devices facilitate the discovery and characterization of genetic markers and aberrant signaling pathways relevant to cardio-brain oncology. Emphasizing innovative diagnostic tools, we examine nanoplatforms for early detection of tumor-specific genetic alterations, real-time monitoring of pathway dysregulation, and precision delivery of therapeutics tailored to the unique molecular landscape of tumors impacting the heart and brain. Additionally, the chapter discusses recent advances in nanoparticle-based imaging, biomarker amplification, and targeted drug delivery systems that address the challenges posed by the complex tumor microenvironment in these sensitive tissues. We also evaluate the translational hurdles, safety concerns, and future directions of integrating nanotechnologies into personalized treatment strategies for patients with cardio-brain cancers. By elucidating the interplay between signaling pathways, genetic markers, and nanomedicine, this chapter aims to provide a comprehensive view of how cutting-edge nanotechnological approaches are shaping the future of diagnosis and therapy in this multidisciplinary field.